Skip to main content

Table 1 Patients characteristics per hospital outcome

From: In-hospital and day-120 survival of critically ill solid cancer patients after discharge of the intensive care units: results of a retrospective multicenter study—A Groupe de recherche respiratoire en réanimation en Onco–Hématologie (Grrr-OH) study

Variable

Hospital decedents

(n = 639)

Hospital survivors

(n = 414)

P value

Male gender

404 (63.2%)

287 (69.3%)

0.05

Age (years)

63 [55–71]

63 [53–71]

0.29

Type of malignancy

   

 Lung

157 (24.6%)

45 (10.9%)

< 0.001

 Colorectal

90 (14.1%)

88 (21.3%)

 Breast

68 (10.6%)

61 (14.7%)

 Head and neck

79 (12.4%)

46 (11.1%)

 Others

245 (38.4%)

174 (42.0%)

Diagnosis to ICU (months)

3 [1–14]

6 [1–36]

 

Cancer status

  

0.002

 Complete remission

99 (15.5%)

90 (21.8%)

 Partial remission

92 (14.4%)

51 (12.4%)

0.004

 Diagnosis during ICU stay

52 (13.0%)

19 (7.5%)

0.04

Distant metastases

384 (60.1%)

177 (42.8%)

< 0.001

Severity at ICU admission

   

 SAPS II

54 [42–72]

39 [30–50]

< 0.001

 SOFA

8 [5–12]

4 [2–7]

< 0.001

Treatments during ICU stay

   

 Invasive mechanical ventilation

518 (81.3%)

203 (49.0%)

< 0.001

 Vasopressors and/or inotropic drug

403 (63.1%)

126 (30.5%)

< 0.001

 Renal replacement therapy

127 (19.9%)

41 (10.0%)

< 0.001

 Cancer chemotherapy

27 (4.4%)

13 (3.3%)

0.48

 Neutropenia during ICU stay

52 (8.2%)

18 (4.4%)

0.02